Sign in
4/A

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-085392

Options or other derivatives

  • Chief Scientific Officer acquired 58,572 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Madison Edwin · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-10-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +58,572 $4.40 2025-10-22 58,572 58,572 D
Loading xslF345X03/doc4a.xml…